Cellect Awarded NIS 3.5 Million BIRD Foundation Grant for the Development and Commercialization of Innovative Stem Cell Selection Technology
15 juin 2016 16h30 HE
|
Cellect Biomed
KFAR SABA, Israel, June 15, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology which enables the functional selection of...
Cellect to be Included in TASE Indices
14 juin 2016 09h02 HE
|
Cellect Biomed
KFAR SABA, Israel, June 14, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or “the Company”), a developer of innovative technology which enables the functional selection of...
Cellect Granted Canadian Patent For Its Cell Selection Technology Platform
09 mai 2016 09h21 HE
|
Cellect Biomed
TEL AVIV, Israel, May 09, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology that enables the functional selection of stem...
Cellect Announces the Signing of a Collaboration Agreement with Accellta
19 avr. 2016 12h00 HE
|
Cellect Biomed
- On the Path to a First License Agreement - TEL AVIV, Israel, April 19, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative...
Cellect Announces Receipt of IRB Approval to Conduct Its Clinical Trial in Leukemia Patients
07 mars 2016 09h00 HE
|
Cellect Biomed
TEL AVIV, Israel, March 07, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, announces today it...
Cellect Announces a NIS 8 Million Private Placement Led by Foreign Investors
16 févr. 2016 09h30 HE
|
Cellect Biomed
TEL-AVIV, Israel, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, announced today the...
Cellect Receives Approval to Commence Human Trial in Healthy Volunteers at the Schneider Medical Center
16 déc. 2015 11h30 HE
|
Cellect Biomed
TEL-AVIV, Israel, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology which enables the functional selection of...
Cellect Announces Positive Results From BMT Safety Test
09 déc. 2015 10h36 HE
|
Cellect Biomed
TEL AVIV, Israel, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem...
Cellect Biomed to Present at ASH 57th Annual Meeting on December 6
02 déc. 2015 11h45 HE
|
Cellect Biomed
TEL AVIV, Israel, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a company specializing in the development of an innovative technology platform which enables the functional...
Cellect Biomed Announces Key Leadership Changes
09 nov. 2015 08h30 HE
|
Cellect Biomed
TEL-AVIV, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem...